Table 1.
Indications/diagnoses/drugs | ICD-10/ATC codes |
Approved indications* | |
Epilepsy | G40; G41 |
Generalised anxiety disorders | F41.1 |
Neuropathic pain-related diagnoses | G35.9; G50.0; G50.1; G51.0; G53.0; G54.4; G54.6; G55.0; G55.1; G56.0; G56.2; G56.4; G56.9; G57.0; G57.1; G57.8; G57.9; G58.0; G58.7; G58.8; G62.9; G63.2; G82.1; G95.0; G95.2; G95.8; G97.9; I69.1; I69.3; M48.0; M50.1; M53.0; M53.1; M54.1; M54.3; M54.4; M79; M89.0; R52 |
Additional neuropathic pain-related diagnoses (broad pattern) | B02; G13.0; G52.1; G56; G57; G58; G59; G60; G61; G62; G63; G99.0; M51.1; M54.2; T92.6; T93.6 |
Substance use disorders† | F11–F19; T42; T43; Z71.4–5 |
Addictive disorder drugs‡ | |
Alcohol | N07BB |
Tobacco | N07BA |
Opioids | N07BC |
Drugs with potential for abuse‡ | |
Opioids | N02A |
Psychostimulants | N06B |
Benzodiazepines | N05B; N05C |
Contemporaneous prescription of gabapentin§ | N03AX12 |
*Diagnoses during the same quarter as the initial prescription.
†At least one diagnosis in two different quarters during the year before the initial prescription.
‡At least one prescription during the year before the initial prescription.
§At least one prescription during the observation period of 1 year.
ATC, Anatomical Therapeutic Chemical; ICD-10, International Classification of Diseases 10th Revision.